|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| Interest credited to policyholders’ account balances | |||||
| Policy charges and fee income | |||||
| Net derivative (gains) losses | |||||
| Credit and intent to sell losses on available-for-sale debt securities and loans | |||||
| Investment (gains) losses, net | |||||
| (Gains) losses on businesses held-for-sale | |||||
| Realized and unrealized (gains) losses on trading securities | |||||
| Loss on novation | |||||
| AB Retirement plan losses | |||||
| Non-cash long term incentive compensation expense | |||||
| Amortization and depreciation | |||||
| Remeasurement of liability for future policy benefits | |||||
| Change in market risk benefits | |||||
| Equity (income) loss from limited partnerships | |||||
| Changes in: | |||||
| Net broker-dealer and customer related receivables/payables | |||||
| Reinsurance recoverable and related balances, net | |||||
| Segregated cash and securities, net | |||||
| Capitalization of deferred policy acquisition costs | |||||
| Future policy benefits | |||||
| Current and deferred income taxes | |||||
| Other, net | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from the sale/maturity/pre-payment of: | |||||
| Fixed maturities, available-for-sale | |||||
| Fixed maturities, at fair value using the fair value option | |||||
| Mortgage loans on real estate | |||||
| Trading account securities | |||||
| Short term investments | |||||
| Other | |||||
| Payment for the purchase/origination of: | |||||
| Fixed maturities, available-for-sale | |||||
| Fixed maturities, at fair value using the fair value option | |||||
| Mortgage loans on real estate | |||||
| Mortgage loans, at fair value using the fair value option | |||||
| Trading account securities | |||||
| Short term investments | |||||
| Other | |||||
| Purchase of business, net of cash acquired | |||||
| Cash from the sale of business, net of cash sold | |||||
| Cash settlements related to derivative instruments, net | |||||
| Investment in capitalized software, leasehold improvements and EDP equipment | |||||
| Other, net | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Policyholders’ account balances: | |||||
| Deposits | |||||
| Withdrawals | |||||
| Transfers (to) from Separate Accounts | |||||
| Payments of market risk benefits | |||||
| Proceeds from short-term financings | |||||
| Repayment of short-term financings | |||||
| Change in collateralized pledged assets | |||||
| Change in collateralized pledged liabilities | |||||
| (Decrease) increase in overdrafts payable | |||||
| Issuance of long-term debt | |||||
| Repayment of long term debt | |||||
| Repayment of acquisition-related debt obligation | |||||
| Proceeds from collateralized loan obligations | |||||
| Repayment of collateralized loan obligations | |||||
| Proceeds from notes issued by consolidated VIEs | |||||
| Repayment of notes issued by consolidated VIEs | |||||
| Dividends paid on common stock | |||||
| Dividends paid on preferred stock | |||||
| Issuance of preferred stock | |||||
| Redemption of preferred stock | |||||
| Purchase of AllianceBernstein Units | |||||
| Purchase of AB Holding Units to fund long-term incentive compensation plan awards, net | |||||
| Purchase of treasury shares | |||||
| Purchases (redemptions) of noncontrolling interests of consolidated company-sponsored investment funds | |||||
| Distribution to noncontrolling interest of consolidated subsidiaries | |||||
| Change in securities lending | |||||
| Other, net | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Change in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Change in cash of businesses held-for-sale | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental cash flow information: | |||||
| Interest paid | |||||
| Federal | |||||
| State | |||||
| California | |||||
| New Jersey | |||||
| New York | |||||
| Pennsylvania | |||||
| Other state and local | |||||
| Foreign | |||||
| Denmark | |||||
| Japan | |||||
| Luxembourg | |||||
| Puerto Rico | |||||
| United Kingdom | |||||
| Taiwan | |||||
| Other foreign | |||||
| Income taxes (refunded) paid | |||||
| Non-cash transactions from investing and financing activities: | |||||
| Transfer of securities to reinsurer | |||||
| Transfer of policy loans to reinsurer | |||||
| Securities received in exchange for the 2029 Notes | |||||
| Debt issued in exchange for the 2029 Notes | |||||
| Deconsolidated trading securities | |||||
| Deconsolidated redeemable noncontrolling interests | |||||
| Transfer of assets to reinsurer | |||||
Loading...